Clinical Study with Pre-Alzheimer’s Condition old
MMT NeuroTech to start First Clinical Study on Pre-Alzheimer’s State
MMT NeuroTech plans on initiating one or more clinical trials to evaluate the effectiveness of two particular medications in the treatment of Preclinical Alzheimer’s disease. These medications are approved by FDA for other indications and have shown promise in preventing the progression of Preclinical
Alzheimer’s disease and / or of Alzheimer’s disease.
Please return to the MMT NeuroTech website periodically to check on the status of these pending studies.